HeadWise HeadWise: Volume 4, Issue 4 | Page 15

For adults with Chronic Migraine,
15 or more headache days a month,
each lasting 4 hours or more,

FOR ADULTS WITH

CHRONIC MIGRAINE

BOTOX® is the first and only preventive treatment
proven to reduce headache days every month.

injection

BOTOX® is the only FDA-approved, preventive treatment that is
injected by a doctor every 3 months for people with Chronic Migraine.
BOTOX® prevents up to 9 headache days a month, versus up to 7 days
for placebo. BOTOX® is not approved for adults with migraine who
have 14 or fewer headache days a month.

Find a headache specialist near you at

BotoxChronicMigraine.com

BOTOX® is a prescription medicine that is injected to prevent headaches in adults with Chronic Migraine who have 15 or more days
each month with headache lasting 4 or more hours each day in people 18 years or older. It is not known whether BOTOX® is safe
or effective to prevent headaches in patients with migraine who have 14 or fewer headache days each month (episodic migraine).
IMPORTANT SAFETY INFORMATION
BOTOX® may cause serious side effects that can be life
threatening. Call your doctor or get medical help right away if
you have any of these problems any time (hours to weeks) after
injection of BOTOX®:
• Problems swallowing, speaking, or breathing, due to weakening
of associated muscles, can be severe and result in loss of life. You
are at the highest risk if these problems are pre-existing before
injection. Swallowing problems may last for several months.

• Spread of toxin effects. The effect of botulinum toxin may affect
areas away from the injection site and cause serious symptoms
including: loss of strength and all-over muscle weakness, double
vision, blurred vision and drooping eyelids, hoarseness or change
or loss of voice (dysphonia), trouble saying words clearly
(dysarthria), loss of bladder control, trouble breathing, trouble
swallowing. If this happens, do not drive a car, operate
machinery, or do other dangerous activities.
There has not been a confirmed serious case of spread of toxin
effect away from the injection site when BOTOX® has been used at
the recommended dose to treat Chronic Migraine.
Please see additional Important Safety Information on adjacent page.

© 2014 Allergan, Inc., Irvine, CA 92612. ® marks owned by Allergan, Inc. Dysport is a registered trademark of Ipsen Biopharm Limited Company.
Myobloc is a registered trademark of Solstice Neurosciences, Inc. Xeomin is a registered trademark of Merz Pharma GmbH & Co KGaA. APC43DI14

www.headaches.org

|

National Headache Foundation

15